Your browser doesn't support javascript.
loading
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Litton, Jennifer K; Beck, J Thaddeus; Jones, Jason M; Andersen, Jay; Blum, Joanne L; Mina, Lida A; Brig, Raymond; Danso, Michael; Yuan, Yuan; Abbattista, Antonello; Noonan, Kay; Niyazov, Alexander; Chakrabarti, Jayeta; Czibere, Akos; Symmans, William F; Telli, Melinda L.
Afiliación
  • Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA.
  • Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA.
  • Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA.
  • Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA.
  • Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA.
  • Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA.
  • Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA.
  • Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy.
  • Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA.
  • Niyazov A; Oncology Value & Evidence, Pfizer Inc., New York, NY, USA.
  • Chakrabarti J; Medical Oncology, Pfizer Ltd., Walton Oaks, Surrey, UK.
  • Czibere A; Oncology Drug Development, Pfizer Inc., Cambridge, MA, USA.
  • Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Oncologist ; 28(10): 845-855, 2023 10 03.
Article en En | MEDLINE | ID: mdl-37318349
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína BRCA1 / Neoplasias de la Mama Triple Negativas Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína BRCA1 / Neoplasias de la Mama Triple Negativas Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido